COVID-19-Bivalent mRNA vaccine SWIM816 (Stemirna Therapeutics)

新冠二价mRNA疫苗SWIM816（斯微生物）

Report date: 2026/05/13 09:11:33

Base Information

Drug NameCOVID-19-Bivalent mRNA vaccine SWIM816 (Stemirna Therapeutics)

Drug Alias Name新冠二价mRNA疫苗SWIM816（BQ.1和XBB）SWIM816SWIM-816

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesStemirna Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesStemirna Therapeutics

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A